Beta Bionics, Inc. Common Stock (BBNX) — Defensive Interval Ratio
Beta Bionics, Inc. Common Stock (BBNX) has a Defensive Interval Ratio of 2190 days as of June 2026. Defensive assets of $156.13 Million (cash $-, short-term investments $136.17 Million, receivables $19.96 Million) cover 2190 days of daily cash needs of $71.28K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Beta Bionics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Beta Bionics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 2190 days, meaning defensive assets of $156.13 Million can fund 2190 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Beta Bionics, Inc. Common Stock.
Annual Defensive Interval Ratio for Beta Bionics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Beta Bionics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Beta Bionics, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2448 days | $207.44 Million | $84.72K/day | $- | $187.55 Million | ▲ +979 days |
| 2024 | 1469 days | $85.14 Million | $57.94K/day | $- | $73.14 Million | ▼ -1099 days |
| 2023 | 2568 days | $74.63 Million | $29.05K/day | $- | $70.18 Million | ▲ +2568 days |
| 2022 | 0 days | $0.00 | $24.31K/day | $- | $0.00 | — |